Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
| ▸ | RELA | Q04206 | 4/20 | 0.38 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23833903 | 0.84 | MEN1 (0.39) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL27317515 | 0.83 | RELA (0.41) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL23072063 | 0.82 | RELA (0.53) | CA1CA2CA12CA7CA14 | |
| Hydrochloric Acid SCHEMBL23834116 | 0.82 | MEN1 (0.38) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL8679104 | 0.79 | CA1 (0.67) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL277303 | 0.79 | CA1 (0.67) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL9665524 | 0.78 | CA1 (0.45) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL694651 | 0.77 | PPARA (0.60) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL1051237 | 0.77 | MEN1 (0.47) | MEN1KMT2ACA1CA2CA12 | |
| SCHEMBL3301732 | 0.77 | ALDH1A1 (0.47) | CA1CA2CA12CA7CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10939684-B2 | Preparation of sulfonamide-containing antimicrobials and substrate treating compositions of sulfonamide-containing antimicrobials | NANO SAFE COATINGS INCORPORATED (US) | 2021-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10939684-B2 | Preparation of sulfonamide-containing antimicrobials and substrate treating compositions of sulfonamide-containing antimicrobials | MSR1, RPS4Y1, MRPS35 | MEN1 3775/4885KMT2A 2764/4885CA1 4297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.